gip and glp-1 agonist Frontiers Dual and Triple Gut Peptide

Packer M, Zile MR, Kramer CM, Baum SJ, Litwin SE, Menon V, et al

What Is Saxenda

doi: 10.1165/rcmb.2015-0311OC [DOI] [PubMed] [Google Scholar] 145

Beginning in 2026, GLP-1 prices are expected to fall 28%, according to Morningstar Equity Research, due to most-favored-nation pricing negotiations with the US

Therefore, these medications deserve consideration as primary cardiovascular drugs rather than merely adjunctive diabetes therapies

In our practice (SN), we routinely use gastric ultrasound (GUS) to guide clinical decision-making, supported by a dedicated team of credentialed POCUS experts available in the operating room